SEC FIlings Archives - Page 16 of 19

03 Feb

SEC FIlings

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

02 Feb

SEC FIlings

Statement of acquisition of beneficial ownership by individuals – Amendment

November 17, 2022
Posted by Jitendra

10 Jan

SEC FIlings

Statement of acquisition of beneficial ownership by individuals

November 17, 2022
Posted by Jitendra

07 Jan

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

08 Dec

SEC FIlings

Quarterly report for quarter ending Sept 30, 2021 – Amendment

November 17, 2022
Posted by Jitendra

07 Dec

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

06 Dec

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

10 Nov

SEC FIlings

Quarterly report for quarter ending Sept 30, 2021

November 17, 2022
Posted by Jitendra

24 Aug

SEC FIlings

Quarterly report for quarter ending June 30, 2021 – Amendment

November 17, 2022
Posted by Jitendra

19 Aug

SEC FIlings

Quarterly report for quarter ending June 30, 2021

November 17, 2022
Posted by Jitendra

SEC FIlings

Statement of acquisition of beneficial ownership by individuals

Statement of acquisition of beneficial ownership by individuals – Amendment

Statement of acquisition of beneficial ownership by individuals

Current report

Quarterly report for quarter ending Sept 30, 2021 – Amendment

Current report

Current report

Quarterly report for quarter ending Sept 30, 2021

Quarterly report for quarter ending June 30, 2021 – Amendment

Quarterly report for quarter ending June 30, 2021

test according

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information

Scilex Holding Company Announces Filing of a New Drug Submission (NDS) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without

Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists